The UK NSC recommendation on Fetomaternal and Neonatal Alloimmune Thrombocytopenia (FMAIT) screening (currently under review)
Find general information about population health screening.
More about FMAIT
When an unborn baby's platelets (cells necessary for blood clotting) are not recognised by the mother's body, she sometimes makes antibodies which attack the baby's platelets (Fetomaternal alloimmune thrombocytopenia, FMAIT). This causes bleeding in the baby in the womb or shortly after birth. Babies can be at serious risk of brain damage or death.
The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
Related documentsSummary of Policy Recommendation and Consultation responses for FMAIT 250713 (PDF document, 42KB, 26/07/13)
More optionsGo to top